Zevenbergen Capital Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,117,876
Closed -$21.6M 89
2022
Q1
$21.6M Sell
1,117,876
-185,662
-14% -$4.26M 0.58% 34
2021
Q4
$42.6M Sell
1,303,538
-35,215
-3% -$1.42M 0.89% 31
2021
Q3
$54.9M Sell
1,338,753
-99,653
-7% -$3.62M 1.04% 32
2021
Q2
$51.8M Sell
1,438,406
-169,017
-11% -$6.24M 0.92% 31
2021
Q1
$62.7M Sell
1,607,423
-51,645
-3% -$2.32M 1.19% 28
2020
Q4
$66.9M Buy
1,659,068
+1,186,078
+251% +$54.5M 1.17% 27
2020
Q3
$26.3M Buy
+472,990
New +$25M 0.53% 35

Other funds holding GDRX

Zevenbergen Capital Investments's GDRX Position: Q2 2022 in Review

Zevenbergen Capital Investments sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 1,117,876 shares — an estimated $21.6M sold.

Zevenbergen Capital Investments first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $66.9M in Q4 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Zevenbergen Capital Investments reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 1,117,876 GoodRx Holdings shares in Q2 2022, an estimated $21.6M.
  • Zevenbergen Capital Investments first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
  • Zevenbergen Capital Investments's GoodRx Holdings position peaked at $66.9M in Q4 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2022, filed 11 Aug 2022.